<p>Merkel cell carcinoma (MCC) is a rare, neuroendocrine skin carcinoma that is caused by the Merkel cell polyomavirus (MCPyV) in 80% of cases and by ultraviolet (UV) damage in 20% of cases. MCC should theoretically elicit a strong cytotoxic T cell response due to the high neoantigen and viral antigen burden in MCPyV- and MCPyV+ MCC, respectively. However, MCC often escapes immune recognition and is associated with very poor prognosis at advanced stages. To systemically identify mechanisms of immune evasion in MCC, we established 11 robust MCC lines from either primary tumors or patient-derived xenografts (7 MCPyV+ and 4 MCPyV-). We then characterized these tumors and cell lines by whole exome sequencing (WES), RNA-sequencing, scRNA-sequencing, ATAC-seq, and whole genome bisulfite sequencing (WGBS). </p><p>We also studied MCC transcriptional subtypes, utilizing bulk and scRNA-sequencing datasets of patient-derived tumors and cell lines to investigate profiles of neuroendocrine gene expression. The genes linked below define either a neuroendocrine or a non-neuroendocrine phenotype presence within MCC tumors. </p>

Characterization of Immune Evasion in Merkel Cell Carcinoma

3 selected publications including "Clinical and molecular characterization of virus-positive and virus-ne..." (94 citations)

Characterization of Immune Evasion in Merkel Cell Carcinoma

Clinical and molecular characterization of virus-positive and virus-negative Merkel cell carcinoma

Reversal of viral and epigenetic HLA class I repression in Merkel cell carcinoma

YAP1 and WWTR1 expression inversely correlates with neuroendocrine markers in Merkel cell carcinoma